If you appreciate this piece and/or my work in general, here's a link to my current UC Berkeley crowdfunding effort: https://crowdfund.berkeley.edu/project/20159 ********** By David Tuller, DrPH As I reported yesterday (oops!--it was Thursday, not yesterday--this is a correction made a few minutes after posting!), the Oxford Health NHS Foundation Trust, which ...

By David Tuller, DrPH On the Mahana Therapeutics website, Robert Paull, the CEO and co-founder, explains in a statement that his personal interest in developing treatments for GI problems arose out of the longtime suffering of a family member. His account is heartfelt and compelling. Unfortunately, Mr Paull and his ...

If you appreciate this piece and/or my work in general, here's a link to my current UC Berkeley crowdfunding effort: https://crowdfund.berkeley.edu/project/20159 ********** By David Tuller, DrPH Since the coronavirus epidemic hit, people with ME have been concerned about the possibility of a secondary wave of post-COVID-19 cases of prolonged disease--especially given ...

By David Tuller, DrPH As the world continues to wrestle with the coronavirus epidemic, President Trump is calling on us here in the US to get back to work. So I decided to start seeking answers again from Mahana Therapeutics, which announced in January that it had licensed a web-based ...

By David Tuller, DrPH Well, it's that time of year again, and it can't be avoided--even in a pandemic. As many of you know, my ongoing investigation of bad research into ME, CFS, so-called "medically unexplained symptoms," etc., conducted under the "Trial By Error" name on Virology Blog, is my ...